ESTRO 2024 - Abstract Book

S2281

Clinical - Upper GI

ESTRO 2024

4. Mannina EM, Cardenes HR, Lasley FD, Goodman B, Zook J, Althouse S, Cox JA, Saxena R, Tector J, Maluccio M. Role of Stereotactic Body Radiation Therapy Before Orthotopic Liver Transplantation: Retrospective Evaluation of Pathologic Response and Outcomes. Int J Radiat Oncol Biol Phys (2017) 97:931 – 938. doi: 10.1016/j.ijrobp.2016.12.036 5. Sapisochin G, Barry A, Doherty M, Fischer S, Goldaracena N, Rosales R, Russo M, Beecroft R, Ghanekar A, Bhat M, et al. Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis. J Hepatol (2017) 67:92 – 99. doi: 10.1016/j.jhep.2017.02.022 6. Gresswell S, Tobillo R, Hasan S, Uemura T, Machado L, Thai N, Kirichenko A. Stereotactic body radiotherapy used as a bridge to liver transplant in patients with hepatocellular carcinoma and Child- Pugh score ≥8 cirrhosis. J Radiosurg SBRT (2018) 5:261 – 267. 7. Uemura T, Kirichenko A, Bunker M, Vincent M, Machado L, Thai N. Stereotactic Body Radiation Therapy: A New Strategy for Loco-Regional Treatment for Hepatocellular Carcinoma While Awaiting Liver Transplantation. World J Surg (2019) 43:886 – 893. doi: 10.1007/s00268-018-4829-x 8. Wang Y-F, Dai Y-H, Lin C-S, Chang H-C, Shen P-C, Yang J-F, Hsiang C-W, Lo C-H, Huang W-Y. Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series. Radiat Oncol (2021) 16:15. doi: 10.1186/s13014-020-01739-5 Walter F, Fuchs F, Gerum S, Rottler MC, Erdelkamp R, Neumann J, Nierer L, Guba M, De Toni EN, Seidensticker M, et al. HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience. Front Oncol (2021) 11:717792. doi: 10.3389/fonc.2021.717792 10. Garg R, Foley K, Movahedi B, Masciocchi MJ, Bledsoe JR, Ding L, Rava P, Fitzgerald TJ, Sioshansi S. Outcomes After Stereotactic Body Radiation Therapy as a Bridging Modality to Liver Transplantation for Hepatocellular Carcinoma. Adv Radiat Oncol (2021) 6:100559. doi: 10.1016/j.adro.2020.08.016 9.

3162

Digital Poster

Proton Therapy for Unresectable and Medically Inoperable Locally Advanced Pancreatic Cancer

Ahmed Gawish 1,2 , Fabian Eberle 1,2 , Markus Schymalla 1,2 , Hilke Vorwerk 1,2 , Sebastian Adeberg 1,2

1 University Hospital Marburg, Radiation Oncology, Marburg, Germany. 2 Marburg Ion-Beam Therapy Center, Radiation oncology, Marburg, Germany

Purpose/Objective:

While proton beam radiation therapy (PBT) potentially enhances the therapeutic effectiveness of radiation treatment for locally advanced pancreatic cancer (LAPC) compared to photon-based methods, existing data is primarily from single-center studies. This research investigates the side effects, survival rates, and disease control outcomes of LAPC patients treated with PBT in our facility.